Skip to main content
Egyptian Rheumatology and Rehabilitation
Download PDF

Study of serum sclerostin levels in association to entheseal ultrasonography in Egyptian psoriatic arthritis patients

Egyptian Rheumatology and Rehabilitation volume 44, pages 45–51 (2017)Cite this article

Abstract

Introduction

Serum sclerostin is a protein inhibitor of the wingless signaling pathway of bone formation whose role in osteoimmunology and inflammatory arthritides is still controversial.

Aim

The aim of the present study was to examine the relation of serum sclerostin as one member of the wingless signal protein inhibitors to arthritic and bony manifestation of psoriasis as a model of autoimmune inflammatory arthritis.

Settings and design

This was a cross-sectional, prospective study.

Patients and methods

The study included 30 psoriatic arthritis (PsA) male patients whose mean age was 43.3±8.3 years and had a disease duration of 3.8±2.6 years, and 15 age-matched and sex-matched apparently healthy controls. Serum sclerostin was measured using the enzyme-linked immunosorbent assay. Disease activity was measured using the Disease Activity Index for Psoriatic Arthritis. Ultrasonography of enthesis at Leeds enthesitis sites and dual energy X-ray absorptiometry at the lumbar spine were also carried out for all patients.

Statistical analysis

The independent t-test, Pearson’s correlation coefficient, and one-way analysis of variance were used for statistical analysis.

Results

The serum sclerostin level was significantly higher in PsA patients compared with controls, with a mean of 0.64 and 0.37 ng/ml, respectively. Serum sclerostin correlated significantly with Disease Activity Index for Psoriatic Arthritis, ultrasonography inflammatory and damage scores, and dual energy X-ray absorptiometry at the lumbar spine.

Conclusion

Serum sclerostin could have a significant role in the development of inflammation-associated bone damage in PsA. Further follow-up studies are recommended to confirm the role of serum sclerostin in inflammation and bone damage in PsA patients and the factors that could regulate this autoimmune pathological event.

References

  1. Rahimi H, Christopher T. Ritchlin altered bone biology in psoriatic arthritis. Curr Rheumatol Rep 2012; 14:349–357.

    Article  Google Scholar 

  2. McGonagle D, Benjamin M, Tan AL. The pathogenesis of psoriatic arthritis and associated nail disease: not autoimmune after all? Curr Opin Rheumatol 2009; 21:340–347.

    Article  CAS  Google Scholar 

  3. Baron R, Rawadi G. Wnt signaling and the regulation of bone mass. Curr Osteoporos Rep 2007; 5:73–80.

    Article  Google Scholar 

  4. Schett G. Effects of inflammatory and anti-inflammatory cytokines on the bone. Eur J Clin Invest 2011; 41:1361–1366.

    Article  CAS  Google Scholar 

  5. Matzelle MM, Gallant M, Condon KW, Walsh NC, Manning CA, Stein GS et al. Resolution of inflammation induces osteoblast function and regulates the Wnt signaling pathway. Arthritis Rheum 2012; 64: 1540–1550.

    Article  CAS  Google Scholar 

  6. Heiland GR, Appel H, Poddubnyy D, Zwerina J, Hueber A, Haibel H, et al. High level of functional Dickkopf-1 predicts protection from syndesmophyte formation in patients with ankylosing spondylitis. Ann Rheum Dis 2012; 71:572–574.

    Article  CAS  Google Scholar 

  7. McGonagle D, Tan AL, Moller Dohn U, Ostergaard M, Benjamin M. Microanatomic studies to define predictive factors for the topography of periarticular erosion formation in inflammatory arthritis. Arthritis Rheum 2009; 60:1042–1051.

    Article  Google Scholar 

  8. Taylor W, Galdman D, Helliwell P, Marchesoni A, Mease P, Mielants H, CASPAR Study Group. Classification criteria for psoriatic arthritis: development of new criteria from a large international study. Arthritis Rheum 2006; 54:2665–2673.

    Article  Google Scholar 

  9. Schoels M, Aletaha D, Funovits J, Kavanaugh A, Baker D, Smolen JS. Application of the DAREA/DAPSA score for assessment of disease activity in psoriatic arthritis. Ann Rheum Dis 2010; 69:1441–1447.

    Article  Google Scholar 

  10. Schoels MM, Aletaha D, Alasti F, Smolen JS. Disease activity in psoriatic arthritis: defining remission and treatment success using the DAPSA-score. Ann Rheum Dis 2016; 75:811–818.

    Article  Google Scholar 

  11. Healy PJ, Helliwell PS. Measuring clinical enthesitis in psoriatic arthritis: assessment of existing measures and development of an instrument specific to psoriatic arthritis. Arthritis Rheum 2008; 59:686–691.

    Article  Google Scholar 

  12. Garrett S, Jenkinson T, Kennedy LG, Whitelock H, Gaisford P, Calin A. A new approach to defining disease status in ankylosing spondylitis: the Bath Ankylosing Spondylitis Disease Activity Index. J Rheumatol 1994; 21: 2286–2291.

    CAS  PubMed  Google Scholar 

  13. Ibrahim G, Groves C, Chandramohan M, Beltran A, Valle R, Reyes B, et al. Clinical and ultrasound examination of the Leeds Enthesitis Index in psoriatic arthritis and rheumatoid arthritis. ISRN Rheumatol 2011; 2011:731917.

    Article  CAS  Google Scholar 

  14. Kanis JA, Melton LJ 3rd, Christiansen C, Johnston CC, Khaltaev N. The diagnosis of osteoporosis. J Bone Miner Res 1994; 9:1137–1141.

    Article  CAS  Google Scholar 

  15. Ibrahim S, Abdelsamad A, Helmy A, Farouk N. Serum sclerostin levels in rheumatoid arthritis. Indian J Rheumatol 2015; 10:117–120.

    Article  Google Scholar 

  16. El-Bakry S, Saber N, Zidan H, Samaha D. Sclerostin as an innovative insight towards understanding rheumatoid arthritis. Egypt Rheumatol 2016; 38:71–75.

    Article  Google Scholar 

  17. Vargas-Muñoz VM, Jimenez-Andrade MC, Villarreal-Salcido JC, Martinez-Martinez A, Acosta-Gonzalez RI, Lugo-Zamudio GE, et al. Association between sclerostin and bone mineral density in a Mexican sample of women with rheumatoid arthritis: a pilot study. J Arthritis 2015; S1 (S1-008):1–6.

    Google Scholar 

  18. Diarra D, Stolina M, Polzer K, Zwerina J, Ominsky MS, Dwyer D, et al. Dickkopf-1 is a master regulator of joint remodeling. Nat Med 2007; 13:156–163.

    Article  CAS  Google Scholar 

  19. Barreira SC, Fonseca JE. The impact of conventional and biological disease modifying antirheumatic drugs on bone biology. Rheumatoid arthritis as a case study. Clin Rev Allergy Immunol 2016; 51:100–109.

    Article  CAS  Google Scholar 

  20. Tahran EF, Demirel B, Kozaci LD, Ozmen M, Turkmen I, Bas Tomas NH, Akar S. Sclerostin and Dickkopf-1 but not Periostin may have a role in psoriatic arthritis [abstract]. Arthritis Rheumatol 2016; 68 (Suppl 10): 1041–1046.

    Google Scholar 

  21. Wehmeyer C, Frank S, Beckmann D, Böttcher M, Cromme C, König U, et al. Sclerostin inhibition promotes TNF-dependent inflammatory joint destruction. Sci Trans Med 2016; 8:330–335.

    Article  Google Scholar 

  22. Amrein K, Amrein S, Drexler C, Dimai HP, Dobnig H, Pfeifer K, et al. Sclerostin and its association with physical activity, age, gender, body composition, and bone mineral content in healthy adults. J Clin Endocrinol Metab 2012; 97:148–154.

    Article  CAS  Google Scholar 

  23. Husic R, Gretler J, Felber A, Graninger WB, Duftner C, Hermann J, Dejaco C. Disparity between ultrasound and clinical findings in psoriatic arthritis. Ann Rheum Dis 2014; 73:1529–1536.

    Article  Google Scholar 

  24. He J, Zhang H, Wang C, Yue H, Hu W, Gu J, et al. Associations of serum sclerostin and polymorphisms in the SOST gene with bone mineral density and markers of bone metabolism in post-menopausal Chinese women. J Clin Endocrinol Metab 2014; 99:E665–E673.

    Article  CAS  Google Scholar 

  25. Paccou J, Mentaverri R, Renard C, Liabeuf S, Fardellone P, Massy ZA, et al. The relationships between serum sclerostin, bone mineral density, and vascular calcification in rheumatoid arthritis. J Clin Endocrinol Metab 2014; 99:4740–4748.

    Article  CAS  Google Scholar 

  26. Padhi D, Allison M, Kivitz A, Gutierrez M, Stouch B, Wang C, Jang G. OP0044 the effects of multiple doses of sclerostin antibody AMG 785 in healthy men and postmenopausal women with low bone mass. Ann Rheum Dis 2013; 71 (Suppl 3):67–68.

    Google Scholar 

  27. Lories RJ, Corr M, Lane NE. To Wnt or not to Wnt: the bone and joint health dilemma. Nat Rev Rheumatol 2013; 9:328–339.

    Article  CAS  Google Scholar 

  28. Marenzana M, Vugler A, Moore A, Robinson M. Effect of sclerostin-neutralising antibody on periarticular and systemic bone in a murine model of rheumatoid arthritis: a micro CT study. Arthritis Res Ther 2013; 15:R125.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Department of Physical Medicine, Rheumatology and Rehabilitation, Faculty of Medicine, Ain Shams University, El Shorouk City, 11957, Cairo, Egypt

    El-Attar A. M. Enas (MD), Farrag A. Dina & El-Mallah E. Reem

  2. Department of Clinical and Chemical Pathology, Faculty of Medicine, Ain Shams University, Cairo, Egypt

    Samaha Y. Dalia

Authors
  1. El-Attar A. M. Enas
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Farrag A. Dina
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. El-Mallah E. Reem
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Samaha Y. Dalia
    View author publications

    You can also search for this author in PubMed Google Scholar

Corresponding author

Correspondence to El-Attar A. M. Enas.

Additional information

This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 3.0 License, which allows others to remix, tweak, and build upon the work noncommercially, as long as the author is credited and the new creations are licensed under the identical terms.

Rights and permissions

This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/.

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Enas, EA.A.M., Dina, F.A., Reem, EM.E. et al. Study of serum sclerostin levels in association to entheseal ultrasonography in Egyptian psoriatic arthritis patients. Egypt Rheumatol Rehabil 44, 45–51 (2017). https://doi.org/10.4103/err.err_63_16

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.4103/err.err_63_16

Keywords